Dominic P. Renda Jr. Joins Wellysis as Chief Commercial Officer

Wellysis has welcomed a new member to its top executive team, appointing Dominic P. Renda Jr. as chief commercial officer (CCO).

In this newly created role, Renda will directly report to CEO/Co-Founder Young Juhn and lead global commercial strategy, market expansion, customer success, and revenue growth, advancing Wellysis’ mission to transform wellness, care, access, and patient outcomes through advanced technology solutions for cardiac health, remote patient monitoring (RPM), hospital-at-home programs, real-time virtual care, and research.

“Dominic’s leadership and deep expertise in scaling high-growth technology companies will be invaluable as Wellysis expands globally,” Juhn stated. “We are excited to accelerate innovation, forge strategic partnerships, and redefine the future of digital health with his leadership.”

With more than 25 years of executive leadership in healthcare technology, software, and high-growth enterprises, Renda has driven billion-dollar IPOs, scaled global businesses, and forged strategic industry partnerships. His expertise in enterprise technology, SaaS, PaaS, medical wearables, and artificial intelligence (AI)-powered healthcare positions him to lead Wellysis into its next phase of market leadership, according to company executives.

Renda’s executive leadership has been instrumental in:

• Scaling VivaLNK from a niche provider to a global leader in digital health.
• Driving InterSystems Corporation’s enterprise healthcare platforms, now powering 1 billion-plus patient records worldwide.
• Leading NetObjects’ $1.5 billion initial public offering and guiding Partnerpedia to its acquisition by BMC Software.
• Founding Oceanseed Project, a nonprofit advancing global health, youth empowerment, and sustainability.

“I am honored to join Wellysis at this pivotal moment in digital health,” Renda said. “Wellysis’ validated, cutting-edge, remote monitoring, predictive analytics, and artificial intelligence are setting new standards in wellness creation, cardiac care, real-time patient management, and global healthcare accessibility. I am excited to expand our impact and bring this life-changing innovation to millions worldwide.”

Founded in 2019 as a Samsung SDS spin-off, Wellysis is at the forefront of real-time monitoring, mobile cardiac telemetry, and AI-powered healthcare. Its flagship S-Patch wearable ECG monitor (S-Patch) delivers real-time cardiac insights, empowering clinicians and patients worldwide. With more than 1,000 hospitals and clinics globally, Wellysis drives innovation and strives to expand its market footprint.